Laboratories seeking to buy follistatin peptide require analytical-grade formulations validated for structural integrity and biological activity. PX1 Research provides USA-manufactured follistatin research compounds engineered specifically for in vitro receptor assays, myostatin binding studies, and cellular signaling research. Every peptide lot undergoes comprehensive testing via RP-HPLC and mass spectrometry to guarantee high purity and absolute batch-to-batch consistency.
Laboratories seeking to buy follistatin peptide require analytical-grade formulations validated for structural integrity and biological activity. PX1 Research provides USA-manufactured follistatin research compounds engineered specifically for in vitro receptor assays, myostatin binding studies, and cellular signaling research. Every peptide lot undergoes comprehensive testing via RP-HPLC and mass spectrometry to guarantee high purity and absolute batch-to-batch consistency.
To buy follistatin peptide for laboratory research, qualified investigators must procure validated, highly purified sequences from certified suppliers capable of supplying full lot traceability. PX1 Research supplies USA-manufactured follistatin variants paired with lot-specific Certificate of Analysis (COA) documentation, verifying >98% purity via RP-HPLC and mass spectrometry for consistent preclinical and in vitro experimental outcomes.
When acquiring research compounds, institutional labs must ensure that the sequence exhibits minimal degradation and negligible endotoxin levels. PX1 Research ensures every batch of follistatin research peptides meets rigorous analytical criteria, preventing experimental confounding in cell culture models or cell signaling assays. All products within our catalog are provided strictly as research peptides for in vitro and preclinical laboratory investigation.
Follistatin is an autocrine single-chain glycoprotein expressed in nearly all vascularized tissues. In nature, it exists in multiple isoform variants derived from alternative splicing of the FST gene. The primary precursor protein, Follistatin-344 (FS-344), undergoes C-terminal cleavage to yield the circulating Follistatin-315 (FS-315) isoform or the membrane-bound Follistatin-288 (FS-288) fragment. Understanding these structural variations is vital when selecting reagents across our all research peptides catalog.
Preclinical studies indicate that FS-344 serves as the precursor transcript frequently utilized in gene expression and recombinant expression vectors. Upon translation and post-translational modification, FS-315 becomes the predominant systemic isoform circulating in plasma, where it binds transforming growth factor-beta (TGF-β) superfamily ligands. Conversely, FS-288 exhibits high heparin-binding affinity, immobilizing it onto cell surface proteoglycans. Selecting the appropriate molecular form allows research teams to precisely isolate paracrine versus endocrine signaling mechanisms.
The primary biochemical function of follistatin revolves around its high-affinity neutralization of specific member proteins within the TGF-β superfamily, most notably Activin A and Myostatin (Growth Differentiation Factor 8 / GDF-8). In vitro binding assays show that follistatin molecules physically encircle the dimerized ligand, sterically blocking its interaction with type I and type II serine/threonine kinase cell surface receptors (such as ActRIIB).
By neutralizing circulating or localized GDF-8, follistatin downregulates the downstream phosphorylation of Smad2 and Smad3 transcription factors. In musculoskeletal cellular models, suppression of the canonical Smad pathway prevents the transcriptional activation of ubiquitin ligases like MuRF1 and MAFbx, thereby inhibiting muscle protein degradation pathways. Researchers exploring myostatin pathway research utilize follistatin as a baseline antagonist to map counter-regulatory cascades across mammalian cell lines.
In published preclinical literature, systemic or tissue-targeted overexpression of follistatin in rodent models demonstrates substantial impacts on skeletal muscle mass maintenance and hypertrophy. Early knockout and transgenic mice studies revealed that animals lacking the myostatin gene or overexpressing follistatin displayed up to two- to three-fold increases in myofiber cross-sectional area compared to wild-type controls.
Beyond skeletal muscle, preclinical models have evaluated follistatin interactions in hepatic, renal, and pulmonary tissue dynamics. In vitro assays using primary hepatocytes indicate that follistatin antagonizes activin-mediated apoptosis, preserving cellular viability under challenging physiological conditions. Furthermore, animal studies exploring fibrotic tissue remodeling suggest that blockade of activin signaling by exogenous follistatin inhibits excessive collagen deposition, making it a pivotal target for cellular fibrosis investigations.
Maintaining rigorous quality standards is essential when sourcing research compounds for advanced laboratory work. Impure reagents introduce unquantified variable proteins, salt residues, or truncations that skew binding kinetics and cellular assay outputs. Qualified research institutions must demand verifiable, independent testing documentation for every purchased lot.
PX1 Research enforces stringent quality control measures operating within ISO 17025 accredited analytical facilities. Every single batch of follistatin undergoes dual verification via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS). These combined methods confirm molecular mass, exact sequence identity, and chemical purity, ensuring research laboratories receive compounds that deliver identical performance from trial to trial. Learn more about our testing standards on our centralized PX1 Research Hub.
For peptides intended for delicate cell culture or receptor-binding studies, purity percentages alone do not tell the complete analytical story. RP-HPLC isolates the main target sequence from chemical synthesis side-products, ensuring a minimum chemical purity threshold of 98%. Simultaneously, mass spectrometry verifies that no truncated peptides or un-deprotected amino acid side chains remain within the lyophilized matrix.
Equally critical for biological assays is the control of bacterial endotoxins (lipopolysaccharides). High endotoxin concentrations trigger non-specific inflammatory signaling cascades via Toll-Like Receptor 4 (TLR4) in cellular models, invalidating experimental conclusions regarding target specificity. PX1 Research assays each batch for endotoxin contamination, delivering materials certified for demanding in vitro protocols.
Proper handling and storage are crucial to maintain the structural stability of recombinant and synthetic proteins. Lyophilized follistatin should be stored at -20°C to -80°C in a desiccated environment upon arrival. Under these conditions, the un-reconstituted powder maintains chemical stability for extended periods.
When preparing follistatin for laboratory assays, reconstitution should occur under sterile laminar flow hoods using bacteriostatic water, sterile phosphate-buffered saline (PBS), or dilute acetic acid depending on specific experimental assay protocols. The reconstituted solution should be gently swirled rather than vortexed to prevent protein denaturation or aggregation caused by shear stress. Once reconstituted, stock solutions should be aliquoted into single-use microcentrifuge tubes and stored at -80°C, avoiding repeated freeze-thaw cycles that compromise tertiary structure.
In musculoskeletal and cellular proliferation research, investigators frequently compare the mechanistic pathways of follistatin against other specialized signaling agents. While follistatin operates predominantly through the extracellular neutralization of TGF-β ligands, other compounds target distinct cellular pathways to influence intracellular synthesis and cellular regeneration.
For instance, researchers comparing muscle hypertrophic pathways often evaluate IGF-1 LR3 alongside follistatin. IGF-1 LR3 stimulates the Akt/mTOR kinase cascade directly through the Receptor Tyrosine Kinase (RTK) pathway, promoting protein translation. Conversely, compounds such as CJC-1295 DAC modulate systemic growth hormone secretion via G-protein coupled receptors, while regenerative peptides like BPC-157 focus primarily on focal adhesion kinase and angiogenic pathways. Combining these distinct mechanisms in comparative in vitro studies allows scientists to map overlapping cellular networks.
Academic laboratories, biotechnology firms, and institutional researchers demand consistent supply chain security and swift order execution. PX1 Research maintains state-of-the-art storage facilities in California and Arizona, enabling same-day dispatch for orders placed Monday through Friday prior to cutoff times.
For high-throughput screening initiatives or long-term multi-phase projects, our wholesale peptide program provides specialized fulfillment solutions, volume pricing, and dedicated lot reservation. By managing domestic manufacturing and internal analytical validation, PX1 Research eliminates supply disruptions and guarantees reliable delivery of research-grade materials to laboratories across the United States.
What is the primary application when buying Follistatin peptide for research?
Follistatin peptide is purchased strictly for in vitro assays, receptor binding studies, and animal model research investigating TGF-β superfamily signaling, specifically the inhibition of Myostatin and Activin A.
What is the structural difference between Follistatin-315 and Follistatin-344?
Follistatin-344 is the precursor peptide transcript that undergoes post-translational modification and cleavage to produce Follistatin-315, the primary systemic circulating isoform, or Follistatin-288, which exhibits high tissue-binding affinity.
How does PX1 Research verify the purity of Follistatin peptide?
PX1 Research utilizes an ISO 17025 accredited laboratory to perform Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS), confirming sequence mass and ensuring chemical purity exceeds 98%.
Why is low endotoxin content important in Follistatin research compounds?
Bacterial endotoxins can trigger non-specific inflammatory pathways (such as TLR4 activation) in cell cultures, skewing experimental results. PX1 Research tests every lot to ensure low endotoxin levels suitable for biological assays.
How should lyophilized Follistatin peptide be stored upon delivery?
Lyophilized Follistatin should be kept in a desiccated freezer at -20°C to -80°C. After sterile reconstitution, stock aliquots should be stored at -80°C to preserve structural integrity and prevent degradation.
Can Follistatin peptide be reconstituted in standard phosphate-buffered saline (PBS)?
Yes, depending on laboratory assay protocols, Follistatin can be reconstituted in sterile PBS or bacteriostatic water under sterile conditions. Vortexing should be avoided to prevent protein aggregation.
Does PX1 Research provide bulk pricing for institutional research laboratories?
Yes, PX1 Research supports academic and institutional research facilities through our wholesale peptide program, offering volume pricing, custom synthesis, and single-lot reservation options.
Is Follistatin peptide approved for human administration or medical use?
No. Follistatin is strictly a research-grade chemical compound intended solely for in vitro laboratory analysis and preclinical scientific research. It is not for human, clinical, or therapeutic use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.